Association of Corporate Counsel (ACC)



Australia challenge ignited by the US success in invalidating patents on cancer gene

Following from the recent significant decision by the US New York's District Court which, as we reported in our April edition, held that Myriad Genetic Inc.'s (Myriad) patents on DNA sequences related to the human breast cancer gene were invalid, that decision has sparked a landmark challenge against the validity of Myriad's similar patent in Australia.

Popular related articles

Most popular articles on Lexology

If you are interested in submitting an article to Lexology, please contact Andrew Teague at ateague@lexology.com.

© Copyright 2006-2010 Globe Business Publishing Ltd